Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments

International Psychogeriatrics

Volumn 19, Issue 3, 2007, Pages 409-420

  Lyketsos, Constantine G ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Behavioral symptoms; Classification; Dementia; Measurement; Neuropsychiatric symptoms; Treatment

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NOOTROPIC AGENT;

ACTIMETRY; ALZHEIMER DISEASE; BEHAVIOR; BEHAVIOR DISORDER; CAREGIVER BURDEN; CLINICAL FEATURE; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DEPRESSION; DISABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG TARGETING; EMPIRICISM; HEALTH CARE UTILIZATION; HUMAN; MENTAL DISEASE; NEUROPSYCHIATRY; PSYCHOSIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SYMPTOM; SYNDROME;

AGED; ALZHEIMER DISEASE; CLINICAL TRIALS; GERIATRIC ASSESSMENT; HUMANS; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 34248229332     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S104161020700484X     Document Type: Conference Paper

References (36)

1. Aalten, P., de Vugt, M. E., Jaspers, N., Jolles, J. and Verhey, F. R. (2005). The course of neuropsychiatric symptoms in dementia. Part II: Relationships among behavioural sub-syndromes and the influence of clinical variables. International Journal of Geriatric Psychiatry, 20, 531-536.
2. Alexopoulos, G. S., Abrams, R. C., Young, R. C. and Shamoian, C. A. (1988). Cornell Scale for Depression in Dementia. Biological Psychiatry, 23, 271-284.
3. Ballard, C. G. et al. (1995). Classification of psychotic symptoms in dementia sufferers. Acta Psychiatricia Scandinavica, 92, 63-68.
4. Burdick, D. J. et al. (2005). Predictors of functional impairment in residents of assisted living facilities: the Maryland Assisted Living Study (MD-AL). Journal of Gerontology, Biological Sciences and Medical Sciences, 60, 258-264.
5. Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308-2314.
6. Gonzales-Salvador, T. et al. (2000). Quality of life of patients with dementia in long-term care. International Journal of Geriatric Psychiatry, 15, 181-189.
7. Hope, T., Keene, J., Fairburn, C., McShane, R. and Jacoby, R. (1997). Behaviour changes in dementia. Part 2: Are there behavioural syndromes? International Journal of Geriatric Psychiatry, 12, 1074-1078.
8. Jeste, D. V. and Finkel, S. I. (2000). Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. American Journal of Geriatric Psychiatry, 8, 29-34.
9. Lee, H. B. and Lyketsos, C. G. (2003). Depression in Alzheimer's disease: heterogeneity and related issues. Biological Psychiatry, 54, 353-336.
10. Livingston, G., Johnston, K., Katona, C., Paton, J. and Lyketsos, C. G. (2005). Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. American Journal of Psychiatry, 162, 1996-2021.
11. Lyketsos, C. G. (2006). Lessons from neuropsychiatry. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 445-449.
12. Lyketsos, C. G. et al. (1997). Major and minor depression in Alzheimer's disease: prevalence and impact. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 556-561.
13. Lyketsos, C. G. et al. (1999). Physical aggression in dementia patients and its relationship to depression. American Journal of Psychiatry, 156, 66-71.
14. Lyketsos, C. G., Steinberg, M., Tschantz, J., Norton, M., Steffens, D. and Breitner, J. C. S. (2001a). Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups. The Cache County Study on Memory in Aging. International Journal of Geriatric Psychiatry, 16, 1043-1053.
15. Lyketsos, C. G., Rabins, P. V. and Breitner, J. C. S. (2001b). An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease. International Journal of Geriatric Psychiatry, 16, 1037-1042.
16. Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., DeKosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. JAMA, 288, 1475-1483.
17. Lyketsos, C. G., Rosenblatt, A. R. and Rabins, P. V. (2004). Forgotten frontal lobe syndrome, or executive dysfunction syndrome. Psychosomatics, 45, 247-255
18. Martin, B. K. et al. (2006). Design of Depression in Alzheimer's Disease Study-2. American Journal of Geriatric Psychiatry, 14, 920-930.
19. Mayer, L. S. et al. (2006). Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS. International Journal of Geriatric Psychiatry, 21, 930-936.
20. Murman, D. L. and Colenda, C. C. (2005). The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden? Pharmacoeconomics, 23, 227-234.
21. Olin, J. T. et al. (2002). National Institute of Mental Health - provisional diagnostic criteria for depression of Alzheimer disease. American Journal of Geriatric Psychiatry, 10, 125-128.
22. Politis, A. M., Vozzella, S., Mayer, L. S., Onyike, C. U., Baker, A. S. and Lyketsos, C. G. (2004). A randomised, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. International Journal of Geriatric Psychiatry, 19, 1087-1094.
23. Pollock, B. G. et al. (2002). Comparison of citalopram, perphenazine and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. American Journal of Psychiatry, 159, 460-465.
24. Rabins, P. V., Lyketsos, C. G. and Steele, C. (2006). Practical Dementia Care, 2nd edition. New York: Oxford University Press.
25. Rosenberg, P. B., Mielke, M. M. and Lyketsos, C. G. (2005). Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study. American Journal of Geriatric Psychiatry, 13, 822-826.
26. Rosenberg, P. R., Johnston, D. and Lyketsos, C. G. (2006). A Clinical Approach to Mild Cognitive Impairment (MCI). American Journal of Psychiatry, 163, 1884-1890.
27. Rosenblatt, A. et al. (2004). The Maryland Assisted Living Study: prevalence, recognition and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland. Journal of the American Geriatrics Society, 52, 1618-1625.
28. Samus, Q. M. et al. (2005). The association of neuropsychiatric symptoms and environment with quality of life in assisted living residents with dementia. Gerontologist, 45 (Suppl. 1), 19-26.
29. Schneider, L. S., Dagerman, K. and Insel, P. S. (2006a). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191-210.
30. Schneider, L. S., Dagerman, K. and Insel, P. S. (2006b). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934-1943.
31. Sink, K. M., Holden, K. F. and Yaffe, K. (2005). Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA, 293, 596-608.
32. Steele, C., Rovner, B., Chase, G. A. and Folstein, M. (1990). Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. American Journal of Psychiatry, 147, 1049-1051.
33. Steinberg, M., Tschanz, J. T., Norton, M., Breitner, J. C. S. and Lyketsos, C. G. (2006). Point and five-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Poster, International Conference on Alzheimer's Disease, Madrid, July 2006.
34. Steinberg, M. and Lyketsos, C. G. (2007). Measures for the non-cognitive neuropsychiatric symptoms of the cognitive disorders. In Handbook of Psychiatric Measures, 2nd edition. Washington DC: American Psychiatric Association.
35. Stern, Y. et al. (1994). Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology, 44, 2300-2307.
36. Weintraub, D. and Katz, I. R. (2005). Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety. Psychiatric Clinics of North America, 28, 941-983.